Dr Suresh Chintalapati is the Founder, President and Chief Business Officer of Triangulum Biopharma. Dr Chintalapati is a Partner and serves on the board as Chief Strategic Adviser for GenomeSense, a Global Molecular Diagnostics Institute. Dr Chintalapati held various Commercial and Business Development positions at Sanford Burnham Prebys Medical Discovery Institute, Illumina, PathwayGenomics and SevenBridges Genomics. Dr Chintalapati is an accomplished scientist with 15 years of research experience in Molecular Biology and Immunology, with over a dozen peer reviewed publications. Dr Chintalapati's post doctoral research was at Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California. Dr Chintalapati has an MS in Biotechnology, PhD in Molecular Biology and an MBA.